<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Arbutus Biopharma Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Arbutus Biopharma Corporation

    Arbutus Biopharma is a publicly-traded (NASDAQ:ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      William H. Collier
    • FOUNDED
      1992
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    CTI BioPharma Corp.

    CTI BioPharma Corp.

    CTI BioPharma is a biopharmaceutical company focused on the acquisition, developme...

    CTI BioPharma is a biopharmaceutical company fo...

    Filing Type:    PU
    Eton Pharmaceuticals, Inc.

    Eton Pharmaceuticals, Inc.

    Eton Pharmaceuticals, Inc. is a Deer Park, IL-based biopharmaceutical company focu...

    Eton Pharmaceuticals, Inc. is a Deer Park, IL-b...

    Filing Type:    PU
    OptiNose, Inc.

    OptiNose, Inc.

    Optinose is a specialty pharmaceutical company focused on creating and bringing to...

    Optinose is a specialty pharmaceutical company ...

    Filing Type:    PU
    Genocea Biosciences, Inc.

    Genocea Biosciences, Inc.

    Genocea is a biopharmaceutical company developing personalized cancer immunotherap...

    Genocea is a biopharmaceutical company developi...

    Filing Type:    PU
    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy ...

    Atara Biotherapeutics is a leading off-the-shel...

    Filing Type:    PU
    Novelion Therapeutics Inc.

    Novelion Therapeutics Inc.

    Novelion Therapeutics Inc. (“Novelion"), headquartered in Vancouver, British Col...

    Novelion Therapeutics Inc. (“Novelion"), head...

    Filing Type:    PU
    Spring Bank Pharmaceuticals, Inc.

    Spring Bank Pharmaceuticals, Inc.

    Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery...

    Spring Bank is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Assembly Biosciences, Inc.

    Assembly Biosciences, Inc.

    Assembly Biosciences is advancing a new class of oral therapeutics for the treatme...

    Assembly Biosciences is advancing a new class o...

    Filing Type:    PU
    Benitec Biopharma Limited

    Benitec Biopharma Limited

    Benitec is a biotechnology company developing a proprietary therapeutic technology...

    Benitec is a biotechnology company developing a...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.